Product Details
Product Details
Product Specification
Species | Human |
Synonyms | Fibroblast growth factor 8b,FGF8 |
Accession | P55075 |
Amino Acid Sequence | Gln23-Arg215 |
Expression System | E.coli |
Molecular Weight | 25kDa (Reducing) |
Purity | >95% by SDS-PAGE |
Endotoxin | <1EU/μg |
Conjugation | Unconjugated |
Tag | No Tag |
Physical Appearance | Lyophilized Powder |
Storage Buffer | 20mM Tris, 150mM NaCl, 1mM EDTA, pH8.0 |
Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
Background
Fibroblast growth factor 8b (FGF-8b), a secreted heparin-binding protein, is a member of the fibroblast growth factor (FGF) family and is an isoform of FGF-8. Alternative splicing of fgf-8 gene gives rise to potentially four (a, b, e, f) different protein isoforms in human, and FGF-8b exhibits the highest transforming activity in NIH3T3 cells. FGF-8b signals through FGF receptors (FGFRs) to activate PI3K and MAPK pathways. FGF-8b is broadly associated with mitogenic and cell survival activities, and regulates gastrulation, epithelial-mesenchymal transition, and later on mesenchymal to epithelial differentiation during embryonic development. FGF-8b has also been found in peripheral blood leukocytes and healthy bone marrow samples.
Picture
Picture
Bioactivity

SDS-PAGE


